The importance of dual 5a-reductase inhibition in the treatment of male pattern hair loss. Olsen E. et. al. SUMMARY In the study, 416 men with male pattern hair loss (MPHL) ages 21 to 45 years old, were randomized to receive dutasteride 0.05, 0.1, 0.5 or 2.5 mg, finasteride 5 mg, or placebo daily for 24 [...]
Dutasteride vs. Finasteride
September 8th, 2009
Rating:
Topic: Hair Transplant
Tags: Dutasteride
Posted by Ethan at Bernstein Medical at 10:58 am
▲ Top of Page
